SciELO - Scientific Electronic Library Online

 
vol.108 issue8  suppl.1Molecular and cellular oncogenic mechanisms in hepatocellular carcinomaHepatocellular carcinoma in sub-Saharan Africa — the way forward author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • On index processSimilars in Google

Share


SAMJ: South African Medical Journal

On-line version ISSN 2078-5135
Print version ISSN 0256-9574

Abstract

DI BISCEGLIE, A M. Prevention of hepatocellular carcinoma with antiviral therapy. SAMJ, S. Afr. med. j. [online]. 2018, vol.108, n.8, suppl.1, pp.47-50. ISSN 2078-5135.  http://dx.doi.org/10.7196/samj.2018.v108i8.13501.

Chronic viral hepatitis types B and C may eventually lead to the development of hepatocellular carcinoma. Although hepatitis B is readily preventable by vaccination, there is growing evidence that antiviral therapy directed against hepatitis B may reduce the risk of liver cancer among those already infected. There is no vaccine against hepatitis C, but the evidence is now strong that antiviral therapy with sustained virological response (viral cure) reduces, but does not eliminate, the risk of hepatocellular carcinoma.

        · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License